Framingham Risk Score Prediction at 12 Months in the STANDFIRM Randomized Control Trial.
Journal:
Journal of the American Heart Association
Published Date:
Apr 16, 2025
Abstract
BACKGROUND: The STANDFIRM (Shared Team Approach Between Nurses and Doctors for Improved Risk Factor Management; ANZCTR registration ACTRN12608000166370) trial was designed to test the effectiveness of chronic disease care management for modifying the Framingham risk score (FRS) among patients with stroke or transient ischemic attack. The primary outcome of change in FRS was not met. We determine baseline characteristics that predict reduction in FRS at 12 months and whether future FRS is predetermined at baseline.